Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Emerging issues with bisphosphonates.

¹Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand. ireid@auckland.ac.nz

Rheumatic Diseases Clinics of North America

|February 10, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-savings from fracture prevention with zoledronate in randomised controlled trials.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Same author

Management of Postmenopausal Osteoporosis.

Endocrine reviews·2026

Same author

Decreased Nonvertebral Fracture Incidence with Zoledronate Use For >3 Years: Post Hoc Analysis of an RCT.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Same author

Antifracture Efficacy of 5- or 10-Yearly Zoledronate in Women Aged 50 to 60 Years: Secondary Analyses of a Randomized Trial.

The Journal of clinical endocrinology and metabolism·2025

Same author

Editorial commentary: Calcium/Vitamin D supplements and the heart.

Trends in cardiovascular medicine·2025

Same author

Development of fatty acid analogues with potent anabolic effects on bone in male mice.

Bone reports·2025

Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026

Same journal

Foreword.

Rheumatic diseases clinics of North America·2026

Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026

Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026

Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026

Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026

See all related articles

Bisphosphonates are key for metabolic bone diseases, but long-term use raises questions. Definitive data is unlikely, so careful patient monitoring is crucial for extended treatment periods.

Area of Science:

Endocrinology
Pharmacology
Bone Biology

Background:

Bisphosphonates are primary treatments for metabolic bone diseases.
Established efficacy but uncertainties regarding long-term application exist.

Purpose of the Study:

To review the current understanding of bisphosphonate use in metabolic bone diseases.
To highlight uncertainties in optimal long-term management strategies.

Main Methods:

Literature review of bisphosphonate therapy in metabolic bone diseases.
Analysis of clinical data and expert opinion on long-term treatment.

Main Results:

Bisphosphonates demonstrate significant therapeutic value.
Optimal duration and long-term safety profiles require further investigation.

Related Experiment Videos

Conclusions:

Definitive clinical trial data for long-term bisphosphonate use is limited.
Clinical vigilance and cautious management are essential for patients on therapy exceeding 10 years.